Miraj Nuclear Medicine And Molecular Ima Ging Center Llp Profile
Key Indicators
- Obligation of Contribution ₹ 1.20 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.65 Cr
About Miraj Nuclear Medicine And Molecular Ima Ging Center Llp
Miraj Nuclear Medicine And Molecular Ima Ging Center Llp (MNMAMIGCL) is 7 Year, 10 Months old Limited Liability Partnership 29 March 2017. Its registered office is in Sangli, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 1.20 M as per MCA.
Company Details
-
Location
Sangli, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAI-9999
-
Incorporation Date
29 Mar 2017
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Pune
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Miraj Nuclear Medicine And Molecular Ima Ging Center Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpesh Shah
|
Designated Partner | 29-Mar-2017 | Current |
|
Samir Joshi
|
Designated Partner | 29-Mar-2017 | Current |
Financial Performance of Miraj Nuclear Medicine And Molecular Ima Ging Center Llp.
Enhance accessibility to Miraj Nuclear Medicine And Molecular Ima Ging Center Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Miraj Nuclear Medicine And Molecular Ima Ging Center Llp?
Unlock access to Miraj Nuclear Medicine And Molecular Ima Ging Center Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sclass Pharmaceuticals LlpSamir Joshi is a mutual person
-
Bio Cab Laboratory Llp
Kalpesh Shah is a mutual person
Charges (Loans)
₹26.50 M
₹0
Charges Breakdown by Lending Institutions
- Siemens Financial Services Private Limited : 1.65 Cr
- Saraswat Co-Operative Bank Ltd. : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Nov 2018 | Saraswat Co-Operative Bank Ltd. | ₹1.00 Cr | Open |
| 17 Sep 2018 | Siemens Financial Services Private Limited | ₹1.65 Cr | Open |
How Many Employees Work at Miraj Nuclear Medicine And Molecular Ima Ging Center Llp?
Unlock and access historical data on people associated with Miraj Nuclear Medicine And Molecular Ima Ging Center Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Miraj Nuclear Medicine And Molecular Ima Ging Center Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Miraj Nuclear Medicine And Molecular Ima Ging Center Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.